These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 39059380)

  • 1. Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype.
    Barrett JR; Pipini D; Wright ND; Cooper AJR; Gorini G; Quinkert D; Lias AM; Davies H; Rigby CA; Aleshnick M; Williams BG; Bradshaw WJ; Paterson NG; Martinson T; Kirtley P; Picard L; Wiggins CD; Donnellan FR; King LDW; Wang LT; Popplewell JF; Silk SE; de Ruiter Swain J; Skinner K; Kotraiah V; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Minassian AM; Lauffenburger DA; Miura K; Long CA; Wilder BK; Koekemoer L; Tan J; Nielsen CM; McHugh K; Draper SJ
    Cell; 2024 Sep; 187(18):4964-4980.e21. PubMed ID: 39059380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of PfRh5-based vaccine efficacy in asymptomatic
    Jun H; Mazigo E; Lee WJ; Louis JM; Syahada JH; Fitriana F; Heo J; Kim Y; Kwon B; Muh F; Lu F; Ahmed MA; Lee SJ; Na S; Chun W; Park WS; Hong M; Han JH; Kwon TH; Lee SU; Han ET; Todd J; Manjurano A; Kidima W; Han JH
    Front Immunol; 2024; 15():1495513. PubMed ID: 39624090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5.
    Mangou K; Moore AJ; Thiam LG; Ba A; Orfanó A; Desamours I; Ndegwa DN; Goodwin J; Guo Y; Sheng Z; Patel SD; Diallo F; Sene SD; Pouye MN; Faye AT; Thiam A; Nunez V; Diagne CT; Sadio BD; Shapiro L; Faye O; Mbengue A; Bei AK
    Sci Rep; 2022 Nov; 12(1):19403. PubMed ID: 36371450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.
    Elias SC; Collins KA; Halstead FD; Choudhary P; Bliss CM; Ewer KJ; Sheehy SH; Duncan CJ; Biswas S; Hill AV; Draper SJ
    J Immunol; 2013 Feb; 190(3):1135-47. PubMed ID: 23293353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax.
    Cao Y; Hayashi CTH; Araujo MDS; Tripathi AK; Andrade AO; Medeiros JF; Vinetz J; Kumar N
    Vaccine; 2024 Aug; 42(21):126140. PubMed ID: 39033079
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chahine ZM; Gupta M; Lenz T; Hollin T; Abel S; Banks C; Saraf A; Prudhomme J; Bhanvadia S; Florens LA; Le Roch KG
    Elife; 2024 Dec; 12():. PubMed ID: 39636094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines and monoclonal antibodies: new tools for malaria control.
    Miura K; Flores-Garcia Y; Long CA; Zavala F
    Clin Microbiol Rev; 2024 Jun; 37(2):e0007123. PubMed ID: 38656211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum.
    Beutler N; Pholcharee T; Oyen D; Flores-Garcia Y; MacGill RS; Garcia E; Calla J; Parren M; Yang L; Volkmuth W; Locke E; Regules JA; Dutta S; Emerling D; Early AM; Neafsey DE; Winzeler EA; King CR; Zavala F; Burton DR; Wilson IA; Rogers TF
    PLoS Pathog; 2022 Mar; 18(3):e1010409. PubMed ID: 35344575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine candidate discovery for the next generation of malaria vaccines.
    Tuju J; Kamuyu G; Murungi LM; Osier FHA
    Immunology; 2017 Oct; 152(2):195-206. PubMed ID: 28646586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systems serology approach to identifying key antibody correlates of protection from cerebral malaria in Malawian children.
    Walker IS; Dini S; Aitken EH; Damelang T; Hasang W; Alemu A; Jensen ATR; Rambhatla JS; Opi DH; Duffy MF; Takashima E; Harawa V; Tsuboi T; Simpson JA; Mandala W; Taylor TE; Seydel KB; Chung AW; Rogerson SJ
    BMC Med; 2024 Sep; 22(1):388. PubMed ID: 39267089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Diawara H; Healy SA; Mwakingwe-Omari A; Issiaka D; Diallo A; Traore S; Soumbounou IH; Gaoussou S; Zaidi I; Mahamar A; Attaher O; Fried M; Wylie BJ; Mohan R; Doan V; Doritchamou JYA; Dolo A; Morrison RD; Wang J; Hu Z; Rausch KM; Zeguime A; Murshedkar T; Kc N; Sim BKL; Billingsley PF; Richie TL; Hoffman SL; Dicko A; Duffy PE;
    Lancet Infect Dis; 2024 Dec; 24(12):1366-1382. PubMed ID: 39153490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RH5 antigenic landscape shapes vaccine and antibody development.
    Patel PN; Tolia NH
    Trends Pharmacol Sci; 2024 Dec; 45(12):1092-1094. PubMed ID: 39510863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire.
    Kucharska I; Binter Š; Murugan R; Scally SW; Ludwig J; Prieto K; Thai E; Costa G; Li K; Horn GQ; Flores-Garcia Y; Bosch A; Sicard T; Rubinstein JL; Zavala F; Dennison SM; Tomaras GD; Levashina EA; Kellam P; Wardemann H; Julien JP
    PLoS Pathog; 2022 Nov; 18(11):e1010999. PubMed ID: 36441829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmepsin X activates the PCRCR complex of Plasmodium falciparum by processing PfRh5 for erythrocyte invasion.
    Triglia T; Scally SW; Seager BA; Pasternak M; Dagley LF; Cowman AF
    Nat Commun; 2023 Apr; 14(1):2219. PubMed ID: 37072430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broadly inhibitory antibodies to severe malaria virulence proteins.
    Reyes RA; Raghavan SSR; Hurlburt NK; Introini V; Bol S; Kana IH; Jensen RW; Martinez-Scholze E; Gestal-Mato M; López-Gutiérrez B; Sanz S; Bancells C; Fernández-Quintero ML; Loeffler JR; Ferguson JA; Lee WH; Martin GM; Theander TG; Lusingu JPA; Minja DTR; Ssewanyana I; Feeney ME; Greenhouse B; Ward AB; Bernabeu M; Pancera M; Turner L; Bunnik EM; Lavstsen T
    Nature; 2024 Dec; 636(8041):182-189. PubMed ID: 39567685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium Falciparum and mosquito vector IgG patterns across suspected malaria cases in Ghana.
    Asare KK; Kwapong SS; Tey P; Sackey V; Nuvor SV; Amoah LE
    BMC Infect Dis; 2024 Dec; 24(1):1374. PubMed ID: 39623362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein.
    Thai E; Murugan R; Binter Š; Burn Aschner C; Prieto K; Kassardjian A; Obraztsova AS; Kang RW; Flores-Garcia Y; Mathis-Torres S; Li K; Horn GQ; Huntwork RHC; Bolscher JM; de Bruijni MHC; Sauerwein R; Dennison SM; Tomaras GD; Zavala F; Kellam P; Wardemann H; Julien JP
    Cell Rep; 2023 Nov; 42(11):113330. PubMed ID: 38007690
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.